MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijid.2022.12.018

Медицинская библиотека · International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022

The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.

Westerhof Ilse, de Hoog Marieke, Ieven Margareta, Lammens Christine, van Beek Janko, Rozhnova Ganna, Eggink Dirk, Euser Sjoerd, Wildenbeest Joanne, Duijts Liesbeth, van Houten Marlies, Goossens Herman, Giaquinto Carlo, Bruijning-Verhagen Patricia

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

We compared age-stratified SARS-CoV-2 symptomatology of wild-type/Alpha vs Omicron BA.1/BA.2 variant infected individuals and the impact of COVID-19 booster vaccination on Omicron symptom burden.

METHODS

Data from three European prospective household cohorts were used (April 2020 to April 2021 and January to March 2022). Standardized outbreak protocols included (repeated) polymerase chain reaction testing, paired serology, and daily symptom scoring for all household members. Comparative analyses were performed on 346 secondary household cases from both periods.

RESULTS

Children <12 years (all unvaccinated) experienced more symptoms and higher severity scores during Omicron compared with wild-type/Alpha period (P ≤0.01). In adults, Omicron disease duration and severity were reduced (P ≤ 0.095). Omicron was associated with lower odds for loss of smell or taste (adjusted odds ratio [aOR]: 0.14; 95% CI 0.03-0.50) and higher but non-significant odds for upper respiratory symptoms, fever, and fatigue (aORs: 1.85-2.23). No differences were observed in disease severity or duration between primary vs booster series vaccinated adults (P ≥0.12).

CONCLUSION

The Omicron variant causes higher symptom burden in children compared with wild-type/Alpha and lower in adults, possibly due to previous vaccination. A shift in symptoms occurred with reduction in loss of smell/taste for Omicron. No additional effect of booster vaccination on Omicron symptom burden was observed.

Для цитирования: Westerhof Ilse, de Hoog Marieke, Ieven Margareta, Lammens Christine, van Beek Janko, Rozhnova Ganna, Eggink Dirk, Euser Sjoerd, Wildenbeest Joanne, Duijts Liesbeth, van Houten Marlies, Goossens Herman, Giaquinto Carlo, Bruijning-Verhagen Patricia. The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2022. DOI: 10.1016/j.ijid.2022.12.018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.